Koers Tiger X Medical Inc Other OTC
Aandelen
US88677A1043
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 700K 651K | Omzet 2025 * | 700K 651K | Marktkapitalisatie | 10,21 mln. 9,49 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -15 mln. -13,94 mln. | Nettowinst (verlies) 2025 * | -19 mln. -17,66 mln. | EV/omzet 2024 * | 14,6 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 14,6 x |
K/w-verhouding 2024 * |
-0,9
x | K/w-verhouding 2025 * |
-0,78
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 70,04% |
Recentste transcriptie over Tiger X Medical Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Peter Altman
CEO | Chief Executive Officer | 57 | 01-01-02 |
David McClung
DFI | Director of Finance/CFO | 61 | 01-09-13 |
Chief Tech/Sci/R&D Officer | - | 01-08-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Stertzer
BRD | Director/Board Member | 88 | 01-01-02 |
Jay Moyes
BRD | Director/Board Member | 70 | 01-01-11 |
Richard Krasno
BRD | Director/Board Member | 82 | 24-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+6,79% | 14,16 mld. | |
+38,61% | 12,63 mld. |
- Beurs
- Aandelen
- Koers BCDA
- Koers